Nash Duane
Insider CIK 1591098 · VTL See Remarks, Director · AKBA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMUX IMMUNIC, INC. | A Award deriv | 2025-07-16 | 2025-07-18 | 315,000 | — | $0 | 315,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2025-07-16 | 2025-07-18 | 630,000 | — | $0 | 630,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2025-07-16 | 2025-07-18 | 630,000 | — | $0 | 630,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2025-07-16 | 2025-07-18 | 315,000 | — | $0 | 315,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2025-07-16 | 2025-07-18 | 315,000 | — | $0 | 315,000 | SEC↗ |
| IMUX IMMUNIC, INC. | P Buy | 2025-06-13 | 2025-06-16 | 20,000 | $0.83 | $16.6K | 36,032 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2025-06-05 | 2025-06-09 | 560,000 | — | $0 | 560,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2025-06-05 | 2025-06-20 | 570,000 | — | $0 | 570,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2024-12-04 | 2024-12-06 | 300,000 | — | $0 | 300,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2024-12-04 | 2024-12-09 | 300,000 | — | $0 | 300,000 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 9,986 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2024-03-04 | 2024-03-06 | 379,959 | — | $0 | 379,959 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 75,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 90,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 120,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 30,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 15,000 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | D To issuer deriv | 2024-03-04 | 2024-03-06 | 19,973 | — | $0 | 0 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2024-01-17 | 2024-01-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2023-01-02 | 2023-01-06 | 132,000 | — | $0 | 132,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMUX IMMUNIC, INC. | P Buy | 2022-05-12 | 2022-05-13 | 10,000 | $5.03 | $50.3K | 22,032 | SEC↗ |
| IMUX IMMUNIC, INC. | G Gift | 2022-05-12 | 2022-05-13 | 6,000 | — | $0 | 16,032 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2022-03-10 | 2022-03-11 | 75,000 | — | $0 | 75,000 | SEC↗ |
| IMUX IMMUNIC, INC. | P Buy | 2021-08-10 | 2021-08-11 | 1,000 | $9.80 | $9.8K | 15,032 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IMUX IMMUNIC, INC. | P Buy | 2021-05-12 | 2021-05-12 | 4,000 | $12.75 | $51.0K | 14,032 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2021-04-15 | 2021-04-19 | 90,000 | — | $0 | 90,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2020-10-22 | 2020-10-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2020-07-02 | 2020-07-06 | 45,000 | — | $0 | 45,000 | SEC↗ |
| IMUX IMMUNIC, INC. | S Sale | 2019-12-04 | 2019-12-04 | 4,400 | $6.96 | $30.6K | 10,032 | SEC↗ |
| IMUX IMMUNIC, INC. | F Tax w/h | 2019-12-03 | 2019-12-04 | 7,930 | $7.15 | $56.7K | 14,432 | SEC↗ |
| IMUX IMMUNIC, INC. | M Exercise deriv | 2019-12-02 | 2019-12-04 | 22,157 | — | $0 | 864,159 | SEC↗ |
| IMUX IMMUNIC, INC. | M Exercise | 2019-12-02 | 2019-12-04 | 22,157 | — | $0 | 22,362 | SEC↗ |
| IMUX IMMUNIC, INC. | A Award deriv | 2019-07-22 | 2019-07-24 | 29,959 | — | $0 | 29,959 | SEC↗ |
| VTL VITAL THERAPIES INC | D To issuer deriv | 2019-01-11 | 2019-01-14 | 241,670 | — | $0 | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | D To issuer deriv | 2019-01-11 | 2019-01-14 | 93,377 | — | $0 | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2019-01-11 | 2019-01-14 | 886,316 | — | $0 | 886,316 | SEC↗ |
| VTL VITAL THERAPIES INC | D To issuer deriv | 2019-01-11 | 2019-01-14 | 85,000 | — | $0 | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | D To issuer deriv | 2019-01-11 | 2019-01-14 | 85,000 | — | $0 | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | D To issuer deriv | 2019-01-11 | 2019-01-14 | 85,000 | — | $0 | 0 | SEC↗ |
| VTL VITAL THERAPIES INC | D To issuer deriv | 2019-01-11 | 2019-01-14 | 23,344 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2018-06-09 | 2018-06-11 | 85,000 | — | $0 | 85,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2018-02-15 | 2018-02-16 | 1,000 | $14.62 | $14.6K | 21,499 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-10-02 | 2017-10-04 | 1,188 | $19.64 | $23.3K | 22,499 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-07-03 | 2017-07-06 | 990 | $14.27 | $14.1K | 23,687 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2017-06-10 | 2017-06-13 | 85,000 | — | $0 | 85,000 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2017-06-08 | 2017-06-09 | 3,900 | $3.12 | $12.2K | 8,224 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-04-03 | 2017-04-04 | 991 | $9.20 | $9.1K | 24,677 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2017-01-03 | 2017-01-03 | 1,980 | $10.46 | $20.7K | 25,668 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-10-03 | 2016-10-04 | 1,981 | $8.96 | $17.7K | 27,648 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2016-07-06 | 2016-07-07 | 1,980 | $7.48 | $14.8K | 29,629 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-06-16 | 2016-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2016-05-13 | 2016-05-17 | 85,000 | — | $0 | 85,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-10-02 | 2015-10-05 | 996 | $8.65 | $8.6K | 31,609 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-07-02 | 2015-07-06 | 996 | $9.53 | $9.5K | 32,605 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2015-06-10 | 2015-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-04-02 | 2015-04-06 | 996 | $9.09 | $9.1K | 12,016 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-04-02 | 2015-06-09 | 996 | $9.09 | $9.1K | 12,016 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2015-04-01 | 2015-04-06 | 1,980 | $9.51 | $18.8K | 13,012 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2015-04-01 | 2015-06-09 | 1,980 | $9.51 | $18.8K | 13,012 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-01-02 | 2015-06-09 | 995 | $11.46 | $11.4K | 12,814 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2015-01-02 | 2015-01-05 | 995 | $11.46 | $11.4K | 12,814 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2015-01-01 | 2015-06-09 | 1,980 | $11.64 | $23.0K | 13,809 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2015-01-01 | 2015-01-05 | 1,980 | $11.64 | $23.0K | 13,809 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2014-12-26 | 2015-06-09 | 5,169 | $11.19 | $57.8K | 11,829 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2014-12-26 | 2015-01-05 | 5,169 | $11.19 | $57.8K | 11,829 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2014-12-26 | 2014-12-29 | 5,169 | $11.19 | $57.8K | 11,829 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2014-12-24 | 2015-06-09 | 6,764 | $11.26 | $76.2K | 16,998 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2014-12-24 | 2015-01-05 | 6,764 | $11.26 | $76.2K | 16,998 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2014-12-24 | 2014-12-29 | 6,764 | $11.26 | $76.2K | 16,998 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2014-12-23 | 2015-06-09 | 23,762 | $11.54 | $274.2K | 23,762 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2014-12-23 | 2015-01-05 | 23,762 | $11.54 | $274.2K | 23,762 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2014-12-23 | 2014-12-29 | 23,762 | $11.54 | $274.2K | 23,762 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2014-10-08 | 2014-10-09 | 100 | $17.50 | $1.8K | 9,324 | SEC↗ |